Search

Katsina School Medication Scare: Students Recover, but Safety and Alleged Beatings Demand Answers

babacares

Katsina School Medication Scare: Students Recover, but Safety and Alleged Beatings Demand Answers

Updated October 29, 2026

A school health exercise intended to protect children from parasitic disease became a medical emergency at Government Science Secondary School, Batagarawa, Katsina State, after students developed vomiting, dizziness and abdominal pain following treatment on October 26.

Early reports identified at least 64 students requiring hospital care. However, an updated police statement reported by Channels Television puts the total affected at 154, saying all have recovered and been discharged, with no deaths recorded.

The recovery offers relief to families, but questions remain about what caused the reactions and how students who complained of illness were treated.

What has been reported?

The exercise involved praziquantel, a medicine used against schistosomiasis, also known as bilharzia. Medical director Dr Auwal Sani confirmed that some students arrived unconscious but responded to treatment. State officials said an investigation would establish the circumstances surrounding the incident.

Allegations of physical punishment

Security analyst Zagazola Makama separately reported allegations that some teachers beat pupils who showed symptoms, accusing them of pretending to be ill.

These allegations have not been independently established in the sources reviewed. They require a separate, fair investigation, including accounts from pupils, staff and medical personnel. The students’ recovery does not resolve the safeguarding concerns raised by those allegations.

A child reporting illness needs assessment and reassurance. Physical punishment must never replace a medical response.

What is schistosomiasis?

Schistosomiasis is a parasitic infection acquired through contact with infested freshwater. It can cause abdominal pain, blood in urine or stool, and, over time, serious organ damage. WHO recommends praziquantel treatment as part of control programmes, alongside safe water, sanitation and other preventive measures.

School treatment campaigns can include children without obvious symptoms. Their inclusion alone does not establish that treatment was inappropriate.

Do these reactions mean the medicine is unsafe?

WHO describes praziquantel as generally well tolerated. Temporary abdominal pain, headache and dizziness can occur; severe reactions are uncommon. This incident therefore requires investigation rather than assumptions about overdose, contamination or negligence.

Reports that doses were determined using students’ heights also need context: WHO recognises a height-based dose pole for school treatment programmes. Its use alone is not evidence of incorrect dosing; investigators must check whether it was applied correctly.

What should improve?

Authorities should publish findings on the medicine supplied, doses administered, staff training, food provision, monitoring and emergency referral arrangements. WHO notes that giving praziquantel with food can reduce the incidence and severity of adverse effects. Whether students had adequate food before treatment remains a question for this investigation.

Future campaigns should clearly explain treatment to families and pupils, provide a safe way to report symptoms, and ensure prompt medical attention when children become unwell.

School health programmes protect children when sound medical practice and respect for their welfare work together. Batagarawa’s students deserve both—and their families deserve clear answers.

READ MORE ON BABACARES.COM, SUBSCRIBE AND SHARE.




Comments
Leave a Reply